Yafang Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yafang Xiao has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Sing Lee
City University of Hong Kong
20 shared publications - Shengliang Li
College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, P. R. China
13 shared publications - Xiao Cui
Center of Super‐Diamond and Advanced Films (COSDAF) Department of Chemistry City University of Hong Kong 83 Tat Chee Avenue Kowloon Hong Kong SAR P. R. China
10 shared publications - Zhongming Huang
College of Pharmaceutical Sciences Soochow University Suzhou 215123 P. R. China
9 shared publications Shuang Tian
Center of Super-Diamond and Advanced Films (COSDAF) & Department of Chemistry, City University of Hong Kong, Kowloon, Hong Kong
8 shared publications- Xiaohong Zhang
Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory of Advanced Negative Carbon Technologies, Soochow University, Suzhou, China
8 shared publications
Latest Publications
- Open Access
- 29 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (43) , e75644
Asymmetrically Coordinated Dual‐Atom Manganese Contrast Agents Enabling High‐Efficiency T1 Enhanced MRI for Precise Tumor Visualization
Achieving atomically precise control over paramagnetic coordination environments is challenging because relaxivity's sixth power dependence on metal water distance demands sub‐angstrom precision while also requiring rapid water exchange, two inherently competing requirements in conventional systems. Here, leveraging dual‐atom coordination engineering as a rational material design strategy, we successfully synthesized a novel dual‐atom manganese‐based platform featuring a well‐defined asymmetric Mn 2 ‐N 3 O 3 geometry anchored on hierarchical boron nitride (Mn‐BN). Notably, this atomic‐level engineering achieves T1 relaxivity of 36.27 mM −1 s −1 at 3.0 T and 15.86 mM −1 s −1 at 7.0 T, approximately 10‐fold higher than those of clinical agents. Combining advanced characterizations with theoretical calculations reveals that adjacent asymmetrically coordinated Mn centers generate cooperative electronic effects that lower water adsorption energy and shorten the Mn–H distance, thereby enhancing water exchange and optimizing dipole–dipole interactions. The Mn‐BN exhibits specific magnetic resonance imaging (MRI) T1 signals for accurate tumor boundary visualization, meanwhile preferential hepatocyte uptake through specific transporters creates differential enhancement for sensitive liver metastases detection. This work positions dual‐atom coordination engineering as an effective materials design strategy for precise enhancement of MRI properties, providing new opportunities for developing advanced contrast agents with tailored biological interactions and extended imaging windows.
- 29 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (43) , e75644
Open AccessAsymmetrically Coordinated Dual‐Atom Manganese Contrast Agents Enabling High‐Efficiency T1 Enhanced MRI for Precise Tumor Visualization
Achieving atomically precise control over paramagnetic coordination environments is challenging because relaxivity's sixth power dependence on metal water distance demands sub‐angstrom precision while also requiring rapid water exchange, two inherently competing requirements in conventional systems. Here, leveraging dual‐atom coordination engineering as a rational material design strategy, we successfully synthesized a novel dual‐atom manganese‐based platform featuring a well‐defined asymmetric Mn 2 ‐N 3 O 3 geometry anchored on hierarchical boron nitride (Mn‐BN). Notably, this atomic‐level engineering achieves T1 relaxivity of 36.27 mM −1 s −1 at 3.0 T and 15.86 mM −1 s −1 at 7.0 T, approximately 10‐fold higher than those of clinical agents. Combining advanced characterizations with theoretical calculations reveals that adjacent asymmetrically coordinated Mn centers generate cooperative electronic effects that lower water adsorption energy and shorten the Mn–H distance, thereby enhancing water exchange and optimizing dipole–dipole interactions. The Mn‐BN exhibits specific magnetic resonance imaging (MRI) T1 signals for accurate tumor boundary visualization, meanwhile preferential hepatocyte uptake through specific transporters creates differential enhancement for sensitive liver metastases detection. This work positions dual‐atom coordination engineering as an effective materials design strategy for precise enhancement of MRI properties, providing new opportunities for developing advanced contrast agents with tailored biological interactions and extended imaging windows.
- Open Access
- 13 May 2025
- Published by Portland Press Ltd. in Essays in Biochemistry
Immune-regulating extracellular vesicles: a new frontier in autoimmune disease therapy
Immune regulation is recognized as a cornerstone therapeutic strategy for the treatment of various autoimmune diseases. These disorders, driven by dysregulated immune responses, contribute significantly to morbidity and mortality. Although conventional immunosuppressive therapies provide symptomatic relief, their prolonged use is often associated with severe adverse effects, underscoring the need for safer and more effective treatment approaches. Extracellular vesicles (EVs), derived from immunoregulatory cells such as regulatory T cells, dendritic cells, mesenchymal stem cells, and neutrophils, have emerged as promising candidates for targeted immunomodulation. These nanoscale vesicles inherit the immunosuppressive properties of their parental cells, thereby facilitating immune homeostasis while mitigating the risks associated with other cell-based therapies. This review provides a comprehensive overview of recent advances in the application of immunoregulatory cell–derived EVs for autoimmune disease treatment, with a particular focus on their mechanisms of action within the immune microenvironment. Finally, we discuss the challenges and potential future directions in the development of EV-based therapies for autoimmune diseases.
- 13 May 2025
- Published by Portland Press Ltd. in Essays in Biochemistry
Open AccessImmune-regulating extracellular vesicles: a new frontier in autoimmune disease therapy
Immune regulation is recognized as a cornerstone therapeutic strategy for the treatment of various autoimmune diseases. These disorders, driven by dysregulated immune responses, contribute significantly to morbidity and mortality. Although conventional immunosuppressive therapies provide symptomatic relief, their prolonged use is often associated with severe adverse effects, underscoring the need for safer and more effective treatment approaches. Extracellular vesicles (EVs), derived from immunoregulatory cells such as regulatory T cells, dendritic cells, mesenchymal stem cells, and neutrophils, have emerged as promising candidates for targeted immunomodulation. These nanoscale vesicles inherit the immunosuppressive properties of their parental cells, thereby facilitating immune homeostasis while mitigating the risks associated with other cell-based therapies. This review provides a comprehensive overview of recent advances in the application of immunoregulatory cell–derived EVs for autoimmune disease treatment, with a particular focus on their mechanisms of action within the immune microenvironment. Finally, we discuss the challenges and potential future directions in the development of EV-based therapies for autoimmune diseases.
- 20 June 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 495
Self-enhanced targeted nanomedicines based on iron starvation acclimation for tumor-specific therapy
- 20 June 2024
- Published by Elsevier in Chemical Engineering Journal
- Vol. 495
Self-enhanced targeted nanomedicines based on iron starvation acclimation for tumor-specific therapy
- Open Access
- 11 February 2024
- Published by Wiley in Advanced Science
- Vol. 11 (15) , e2307063
An Integrated Arterial Remodeling Hydrogel for Preventing Restenosis After Angioplasty
The high incidence of restenosis after angioplasty has been the leading reason for the recurrence of coronary heart disease, substantially increasing the mortality risk for patients. However, current anti‐stenosis drug‐eluting stents face challenges due to their limited functions and long‐term safety concerns, significantly compromising their therapeutic effect. Herein, a stent‐free anti‐stenosis drug coating (denoted as Cur‐NO‐Gel) based on a peptide hydrogel is proposed. This hydrogel is formed by assembling a nitric oxide (NO) donor‐peptide conjugate as a hydrogelator and encapsulating curcumin (Cur) during the assembly process. Cur‐NO‐Gel has the capability to release NO upon β‐galactosidase stimulation and gradually release Cur through hydrogel hydrolysis. The in vitro experiments confirmed that Cur‐NO‐Gel protects vascular endothelial cells against oxidative stress injury, inhibits cellular activation of vascular smooth muscle cells, and suppresses adventitial fibroblasts. Moreover, periadventitial administration of Cur‐NO‐Gel in the angioplasty model demonstrate its ability to inhibit vascular stenosis by promoting reendothelialization, suppressing neointima hyperplasia, and preventing constrictive remodeling. Therefore, the study provides proof of concept for designing a new generation of clinical drugs in angioplasty.
- 11 February 2024
- Published by Wiley in Advanced Science
- Vol. 11 (15) , e2307063
Open AccessAn Integrated Arterial Remodeling Hydrogel for Preventing Restenosis After Angioplasty
The high incidence of restenosis after angioplasty has been the leading reason for the recurrence of coronary heart disease, substantially increasing the mortality risk for patients. However, current anti‐stenosis drug‐eluting stents face challenges due to their limited functions and long‐term safety concerns, significantly compromising their therapeutic effect. Herein, a stent‐free anti‐stenosis drug coating (denoted as Cur‐NO‐Gel) based on a peptide hydrogel is proposed. This hydrogel is formed by assembling a nitric oxide (NO) donor‐peptide conjugate as a hydrogelator and encapsulating curcumin (Cur) during the assembly process. Cur‐NO‐Gel has the capability to release NO upon β‐galactosidase stimulation and gradually release Cur through hydrogel hydrolysis. The in vitro experiments confirmed that Cur‐NO‐Gel protects vascular endothelial cells against oxidative stress injury, inhibits cellular activation of vascular smooth muscle cells, and suppresses adventitial fibroblasts. Moreover, periadventitial administration of Cur‐NO‐Gel in the angioplasty model demonstrate its ability to inhibit vascular stenosis by promoting reendothelialization, suppressing neointima hyperplasia, and preventing constrictive remodeling. Therefore, the study provides proof of concept for designing a new generation of clinical drugs in angioplasty.
- 4 December 2023
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 2 (3) , 244-259
Immunoregulatory nanomedicine for respiratory infections
- 4 December 2023
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 2 (3) , 244-259
Immunoregulatory nanomedicine for respiratory infections
- 27 November 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 479
Hypoxia-triggered tumor specific glutamine inhibition for reversing cisplatin resistance of chemotherapy
- 27 November 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 479
Hypoxia-triggered tumor specific glutamine inhibition for reversing cisplatin resistance of chemotherapy
- 9 August 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (35) , 8528-8540
NIR-II fluorescence and PA imaging guided activation of STING pathway in photothermal therapy for boosting cancer immunotherapy by theranostic thermosensitive liposomes
A versatile PLDD was developed with the light-triggered promotion of anti-tumor immunity and NIR-II fluorescence and PA imaging profiles, soaring the therapeutic effect and providing accurate spatiotemporal imaging for photothermal immunotherapy.
- 9 August 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (35) , 8528-8540
NIR-II fluorescence and PA imaging guided activation of STING pathway in photothermal therapy for boosting cancer immunotherapy by theranostic thermosensitive liposomes
A versatile PLDD was developed with the light-triggered promotion of anti-tumor immunity and NIR-II fluorescence and PA imaging profiles, soaring the therapeutic effect and providing accurate spatiotemporal imaging for photothermal immunotherapy.
- 12 April 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (40) , 4902-4905
Achieving high singlet-oxygen generation by applying the heavy-atom effect to thermally activated delayed fluorescent materials
Applying the heavy-atom effect to TADF photosensitizers achieves ultra-high 1 O 2 generation ( Ф Δ = 0.91) by the synergetic effect of small Δ E ST and considerable SOC.
- 12 April 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (40) , 4902-4905
Achieving high singlet-oxygen generation by applying the heavy-atom effect to thermally activated delayed fluorescent materials
Applying the heavy-atom effect to TADF photosensitizers achieves ultra-high 1 O 2 generation ( Ф Δ = 0.91) by the synergetic effect of small Δ E ST and considerable SOC.
- 7 April 2021
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 13 (17) , 8012-8016
Single molecular nanomedicine with NIR light-initiated superoxide radical, singlet oxygen and thermal generation for hypoxia-overcoming cancer therapy
Molecular nanomedicine (BthB NPs) is developed for effective superoxide radical (O2˙−) generation for hypoxia-overcoming photodynamic therapy (PDT), upon irradiation with an 808 nm laser with a high tissue penetration depth.
- 7 April 2021
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 13 (17) , 8012-8016
Single molecular nanomedicine with NIR light-initiated superoxide radical, singlet oxygen and thermal generation for hypoxia-overcoming cancer therapy
Molecular nanomedicine (BthB NPs) is developed for effective superoxide radical (O2˙−) generation for hypoxia-overcoming photodynamic therapy (PDT), upon irradiation with an 808 nm laser with a high tissue penetration depth.